Abstract
After the implementation of broad vaccination programs, there is an urgent need to understand how the population immunity affects the dynamics of the COVID-19 pandemic in presence of the protection waning and of the emergence of new variants of concern. In the current Omicron wave that is propagating across Europe, assessing the risk of saturation of the healthcare systems is crucial for pandemic management, as it allows us to support the transition towards the endemic course of SARS-CoV-2 and implement more refined mitigation strategies that shield the most vulnerable groups and protect the healthcare systems. We investigated the current pandemic dynamics by means of compartmental models that describe the age-stratified social-mixing, and consider vaccination status, vaccine types, and their waning efficacy. Our results suggest that the current wave is unlikely to create an overwhelming healthcare demand: owing to the lower hospitalization rate of the novel variant and the effectiveness of the vaccines. Our findings are robust with respect to the plausible variability of the main parameters that govern the severity and the progression of the Omicron infection.
Introduction
In early 2022, public health officials faced a significant challenge with the emergence of the Omicron (B.1.1.529) variant. While early data from South Africa and the UK suggested lower intrinsic severity, its unprecedented transmissibility led to record-breaking daily case counts. The central question for policymakers in Germany and Switzerland was whether the sheer volume of infections would saturate hospital and ICU capacities through "brute force" numbers. This paper quantifies that risk, accounting for specific vaccination rates, vaccine types, and social mixing patterns.
Methodology
The research utilized an age-stratified Susceptible-Infected-Removed (SIR) type compartmental model to simulate pandemic progression. The model was refined to include several critical layers:
- Age Stratification: The population was divided into 16 age groups (from 0-4 to 75+) to account for distinct social behaviors and clinical risks.
- Vaccination Dynamics: The model distinguished between unvaccinated, vaccinated, and recently recovered individuals, incorporating waning immunity and the specific efficacy of mRNA and vector-based vaccines.
- Social Mixing: Country-specific contact matrices were used to simulate interactions across various settings.
Key Insights and Results
The most significant finding was the mathematical confirmation of the "decoupling" effect. Because Omicron's hospitalization rate is roughly 56% lower than Delta's and the average hospital stay is much shorter (1.5 days vs. 14 days), healthcare systems can tolerate a much higher incidence ceiling than in previous waves.
Projections for Switzerland and Germany
Under various effective reproduction number ($R_e$) scenarios, the model projected that ICU occupancy would remain below critical thresholds. For Switzerland, even in a worst-case scenario ($R_e = 1.8$), ICU demand was expected to stay well within the available capacity.
Key results include:
- ICU Stability: Occupancy was projected to remain below 7,000-8,000 beds in Germany and 500 in Switzerland.
- Infection Peaks: In aggressive scenarios, 5-10% of the total population was expected to be infected within a single week.
- Vaccine Efficacy: Overall efficacy against hospitalization was estimated at approximately 0.6 for Germany and 0.65 for Switzerland.
Discussion and Operational Risks
While physical bed capacity appeared secure, the study identified workforce depletion as a primary threat. With a high percentage of the population potentially infected simultaneously, the risk of medical staff being quarantined poses a significant operational risk to healthcare delivery.
Limitations
The authors acknowledge that early data on Omicron severity and vaccine waning were still evolving. The model also assumes constant mitigation measures and does not account for the long-term burden of "Long-COVID" or the socio-economic toll of mass infections. However, the framework remains a valuable tool for quantitative support in response to recurring COVID-19 waves.
Summary updated